기사 메일전송
Kinaxis Announces Intention to Maximize Size of Normal Course Issuer Bid
  • 윤문성
  • 등록 2026-02-06 00:32:54

기사수정

Kinaxis® Inc. (https://www.kinaxis.com/en) (“Kinaxis” or the “Company”) (TSX: KXS) today announces that it intends to amend its current normal course issuer bid (https://investors.kinaxis.com/news-releases/news-release-details/2025/Kinaxis-Announces-Normal-Course-Issuer-Bid/default.aspx) (the “NCIB”) to increase the number of its common shares (the “Shares”) that may be repurchased from 1,403,042, representing 5% of the Company’s issued and outstanding Shares as at October 31, 2025, to approximately 2,799,843, representing 10% of the Company’s “public float” as at October 31, 2025, which is the maximum allowable under the rules of the Toronto Stock Exchange (the “TSX”). The Company has already invested US$54 million under its current NCIB. At the average price paid to date for the Shares under the current NCIB, repurchasing 10% of the Shares would represent an additional investment of approximately US$284 million.

“There is a fundamental misunderstanding of the opportunities and threats from generative and agentic AI to mission-critical enterprise software, like ours, that solves deeply complex problems and enables highly consequential decisions. As a result, the public markets may not be fully reflecting the underlying value of Kinaxis from time to time. We see value to shareholders in maximizing our ability to buy back Shares under the NCIB structure or other structures that may also be available to Kinaxis,” said Razat Gaurav, chief executive officer of Kinaxis. “Our substantial moat in industry is built on decades of deep domain knowledge, and our Maestro platform represents the most granular and holistic representation of how underlying supply chains operate. Maestro’s predictions, intelligence and prescriptive decisions are made possible by leveraging a fusion of advanced machine learning, optimization and heuristics. These capabilities are fundamental to supply chain planning and decision making and are enhanced, not replaced, by GenAI, composable agentic AI, and the latest semantic and data architectures to achieve the next generation of supply chain orchestration. We are excited about the possibilities.”

Under the NCIB, to February 3, 2026, Kinaxis has repurchased for cancellation an aggregate of 447,738 Shares (at an average price of C$167.50 per Share). The NCIB commenced on November 12, 2025 and ends on November 11, 2026, or on such earlier date as Kinaxis completes its purchases or provides notice of termination.

Although the Company has a present intention to increase the size of the NCIB, the Company may not do so and will not be obligated to make any purchases and purchases may be suspended by the Company at any time. The amendment to the NCIB is expected to be made once the Company comes out of its existing regularly scheduled blackout period, and is subject to market conditions and receipt of all required approvals, including the approval of the TSX.

About Kinaxis

Kinaxis is a global leader in modern supply chain orchestration, powering complex global supply chains and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro™, combines proprietary technologies and techniques that provide full transparency and agility across the entire supply chain — from multi-year strategic planning to last-mile delivery. We are trusted by renowned global brands to provide the agility and predictability needed to navigate today’s volatility and disruption. For more news and information, please visit kinaxis.com or follow us on LinkedIn.

Cautionary Note and Forward-Looking Information

This press release contains forward-looking information within the meaning of Canadian securities legislation. Forward-looking information relates to future events or the anticipated performance of Kinaxis and reflects management’s expectations or beliefs regarding such future events. In certain cases, statements that contain forward-looking information can be identified by the use of words such as “plans”, “expects”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates”, “believes” or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might”, or “will be taken”, “occur” or “be achieved” or the negative of these words or comparable terminology. Forward-looking information in this press release includes statements with respect to the proposed amendment to the NCIB, the potential future purchases by Kinaxis of Shares pursuant to the NCIB and the benefits of the NCIB. By its very nature forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual performance of Kinaxis to be materially different from any anticipated performance expressed or implied by such forward-looking information.

Forward-looking information is subject to a variety of risks and uncertainties, which could cause actual events or results to differ from those reflected in the forward-looking information, including, without limitation, the risks described under the heading “Risk Factors” in the Company’s annual information form dated February 26, 2025 for its fiscal year ended December 31, 2024 and other risks identified in the Company’s filings with Canadian securities regulators, which filings are available on SEDAR+ at https://www.sedarplus.ca.

The risk factors referred to above are not an exhaustive list of the factors that may affect any of the Company’s forward-looking information. Forward-looking information includes statements about the future and is inherently uncertain, and the Company’s actual achievements or other future events or conditions may differ materially from those reflected in the forward-looking information due to a variety of risks, uncertainties and other factors. The Company’s statements containing forward-looking information are based on the beliefs, expectations, and opinions of management on the date the statements are made, and the Company does not assume any obligation to update such forward-looking information if circumstances or management’s beliefs, expectations or opinions should change, other than as required by applicable law. For the reasons set forth above, one should not place undue reliance on forward-looking information.

SOURCE: Kinaxis Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260204082999/en/

언론연락처: Kinaxis Inc. Media Relations Vanessa Cohen 647-822-8540 Investor Relations Rick Wadsworth 613-907-7613

이 뉴스는 기업·기관·단체가 뉴스와이어를 통해 배포한 보도자료입니다.

0
  • 목록 바로가기
  • 인쇄


최신뉴스더보기
많이 본 뉴스더보기
  1. 서울시 공문서 ‘AI 리더블’로 전면 전환…디지털·경제 전략 점검 서울시가 23일 2026년 신년 업무보고 3일차 회의를 열고 공문서를 AI가 즉각 이해·분석할 수 있도록 표준화하는 ‘AI 리더블 행정문서’ 도입과 함께 디지털·경제·민생·청년 분야의 중점 전략을 점검했다.서울시는 이날 디지털·경제 분야를 중심으로 AI 기반 미래 성장동력 확보와 민생 현장 사회안전망 강화를 ..
  2. 시립목동청소년센터 청소년 동행캠프…환경·힐링으로 겨울방학 채웠다 시립목동청소년센터가 지난 1월 12일부터 23일까지 겨울방학을 맞은 청소년을 대상으로 ‘청소년 동행캠프: Re Born Earth’를 운영해 환경·힐링을 주제로 한 체험형 프로그램을 통해 돌봄 공백 해소와 건강한 성장을 지원했다.서울시가 주최하는 청소년 동행캠프는 방학 기간 자녀 돌봄이 필요한 가정의 부담을 덜고 청소년의 전인..
  3. Microsoft, 2026 대한민국 교육박람회에서 ‘AI 파트너 시대’ 교육 솔루션 제시 Microsoft는 지난 1월 21일부터 23일까지 서울 코엑스에서 열린 ‘2026 대한민국 교육박람회(Education Korea 2026)’에서 ‘AI 파트너 시대(AI Partner Era)’를 주제로 한 교육 솔루션 전시 부스(주최: Microsoft, 주관: 고우넷)를 선보였다. 이번 전시는 AI가 교사와 학생, 관리자의 역할을 보완하며 함께 일하는 동료이자 파트너로 기능하는 교육 환경을 제시...
  4. 한국이 만든 선박용 교체식 배터리 시스템 기준, 국제표준 됐다 선박해양플랜트연구소(KRISO, 소장 홍기용)는 KRISO가 중심이 돼 우리나라 주도로 제안한 ‘선박용 교체식 배터리의 설치 및 운영 요구사항’이 ISO(국제표준화기구)의 국제표준(ISO 18962)으로 공식 제정·발간됐다고 26일 밝혔다. * ISO 18962: 선박 및 해양 기술 - 선박용 교체식 배터리의 설치 및 운영 요구사항(Ships and marine technology - Installation and ope...
  5. 제이디씨파트너스, 아름다운가게와 업무 협약 체결 제이디씨파트너스(대표이사 고봉득)와 아름다운가게(이사장 박진원)는 노사 공동으로 가족참여형 사회공헌 활동 확대를 위해 1월 28일 제주첨단과학기술단지 스마트빌딩에서 업무협약(MOU)을 체결했다. 제이디씨파트너스는 이번 협약을 통해 노사 공동의 정기 물품 기부와 자원봉사(활동천사) 참여체계를 구축하고, 임직원 및 가족이 함께하...
  6. 현대차, 2025년 매출 186조… 2025년 경영실적 발표 현대자동차는 29일 경영실적 컨퍼런스콜을 통해 2025년 연결 기준 매출액 186조2545억원, 영업이익 11조4679억원을 기록하며 미국 관세 등 악재 속에서도 연간 가이던스를 달성했다고 밝혔다.현대차는 2025년 연간 실적으로 도매 판매 413만8389대, 매출액 186조2545억원, 영업이익 11조4679억원, 경상이익 13조8419억원, 당기순이익 10조3648억원을 기록했..
  7. 네오팜, 자체 생산 시설·연구소 보유로 K-뷰티 시장 차별화 전략 내세워 뷰티&헬스케어 기업 네오팜(대표 김양수)은 외주를 통해 제품을 생산하고 연구를 진행하는 경우가 많은 K-뷰티 업계에서 자체 공장 및 연구소 보유라는 독보적인 경쟁 우위를 유지하고 있다고 밝혔다. 2025년 상반기 기준 코스맥스, 한국콜마, 코스메카코리아, 씨앤씨인터내셔널 등 ‘ODM 빅 4’ 매출은 전년 동기 대비 10% 이상 성장한 것으로 ...
모바일 버전 바로가기